 |
|
 | |
 | ||
 Latest NewsThe hospital opened the Maternity and Delivery floor in May 2009 after a total renovation. All the patient rooms have been renewed to provide women with a comfortable environment while they are in the hospital. This is the first step in creating a department dedicated to women’s health. Hammoud Hospital and the American University of Beirut Medical Center have formed an affiliation between the hospital Pathology Departments. Calendar of Events |
Welcome to Hammoud Hospital.
Medical News from Web MDMediterranean Diet May Prevent Stroke-Related Brain DamageFollowing a Mediterranean diet may help lower risk of brain damage related to silent strokes, new research shows. 8 February 2010, 5:39 pm Less TV, More Family Dinners Fight Childhood ObesitySimple lifestyle habits at home, such as having more family meals, could reduce obesity in preschoolers, new research suggests. 8 February 2010, 4:47 pm Nearly 1 in 3 Overweight Teens in DenialNearly one in three overweight adolescents don't think they have a weight problem. 8 February 2010, 3:38 pm Thirdhand Smoke Creates Indoor Cancer RiskTobacco smoke residue, or “thirdhand” smoke, mixes with indoor air pollutants to form cancer-causing substances. 8 February 2010, 3:04 pm Autism Risk Rises With Mother's AgeRegardless of the father's age, a child's risk of autism rises with the age of the child's mother. Moms 40 and older are 77% more likely to have a child with autism, compared to mothers under age 25. 8 February 2010, 2:59 pm News from The New England Journal of MedicineOral Fingolimod or Intramuscular Interferon for Relapsing Multiple SclerosisIn this 12-month trial involving patients with relapsing-remitting multiple sclerosis, oral fingolimod was more effective than intramuscular interferon beta-1a in reducing relapse rates. Adverse events associated with fingolimod included herpesvirus infections (two fatal infections), atrioventricular block, macular edema, skin cancer, and liver-enzyme elevation. 3 February 2010, 4:55 pm A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple SclerosisIn this 24-month, randomized trial involving patients with relapsing-remitting multiple sclerosis, oral fingolimod reduced the rates of relapse and disability progression, as compared with placebo. Adverse events reported in patients treated with fingolimod included bradycardia, atrioventricular conduction block, macular edema, elevations in liver-enzyme levels, and mild hypertension. 3 February 2010, 4:55 pm CME: Under Pressure(No abstract is available for this citation) 3 February 2010, 4:55 pm CME: Jet Lag(No abstract is available for this citation) 3 February 2010, 4:55 pm CME: A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis(No abstract is available for this citation) 3 February 2010, 4:55 pm |
QUALITY UPDATESHammoud Hospital University Medical Center places the highest priority on its commitment to practicing medicine in a way that consistently delivers the safest care possible for every patient. The Hammoud Hospital continues to work hard to maintain its ISO 9001 accreditation. Improving Every Day Since 1966Our approach to patient care encompasses our commitment to safety, effectiveness, patient centeredness, timeliness, efficiency and equity – an approach that is always evolving based on the latest research findings. |
The Hammoud Hospital University Medical Center is a 325-bed facility that treats more than 24,000 patients/year and performs more than 10,000 surgeries/year. The hospital has one of the biggest Cardiac programs in Lebanon and performs the highest number of renal transplants in the country.| Hammoud Hospital University Medical Center Dr. Ghassan Hammoud Street P.O.Box: 652 Saida, Lebanon Phone: +961-7-723-111 Fax: +961-7-725-833 General Information: info@hammoudhospital.com The Webmaster: webmaster@hammoudhospital.com |